ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO1573

Baseline Characteristics and Associations with Renal Function in a Greek Cohort of Polycystic Kidney Disease

Session Information

Category: Genetic Diseases of the Kidneys

  • 1001 Genetic Diseases of the Kidneys: Cystic

Authors

  • Tsirpanlis, George I., Nephrology Department of General Hospital of Athens "G. Gennimatas", Athens, Attiki, Greece
  • Kostopoulou, Myrto, Nephrology Department of General Hospital of Athens "G. Gennimatas", Athens, Attiki, Greece
  • Louka, Michaela, Nephrology Department of General Hospital of Athens "G. Gennimatas", Athens, Attiki, Greece
  • Kanellopoulou, Konstantina, Nephrology Department of General Hospital of Athens "G. Gennimatas", Athens, Attiki, Greece
  • Gkika, Vasiliki, Nephrology Department of General Hospital of Athens "G. Gennimatas", Athens, Attiki, Greece
  • Fokas, Stavros, Nephrology Department of General Hospital of Athens "G. Gennimatas", Athens, Attiki, Greece
  • Koutsogianni, Anastasia Karolina, Magnetic Resonance Department, General Hospital of Athens, “G. Gennimatas”, Athens, Attiki, Greece
  • Lymperopoulos, Konstantinos, Magnetic Resonance Department, General Hospital of Athens, “G. Gennimatas”, Athens, Attiki, Greece
Background

Recent advances in the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) highlight the interplay between the clinical and the laboratory profile of the disease. This study aims to present the baseline characteristics of patients followed in a large ADPKD cohort from a single center in Greece, and explore possible associations between demographic, clinical and laboratory parameters

Methods

Patients followed in a specialized outpatient PKD clinic from December 2018 up to December 2019 were recruited in this study. At enrollment, demographics, medical and family history and laboratory data were recorded using a standardized form. Estimated glomerular filtration rate (eGFR) was calculated and Magnetic Resonance Imagining for total kidney volume (TKV) measurement was performed

Results

One-hundred three females and 83 males with a mean age±SD of 41.4 ± 13 years (18.8 % < 30 years) were enrolled. Overall, 60.8% of them were classified as Chronic Kidney Disease, (CKD) stage 1 and 2. The ADPKD was diagnosed at a mean age±SD of 26.5±12.5 years. Thirty four percent out of 186 patients were diagnosed before the age of 20 and 9% of them before the age of 10. A positive family history was present in 89% of patients. In this subgroup, the median age of the affected parent that reached end stage renal disease (ESRD) was 55 (range 28-87) years. Hypertension was diagnosed in 89% at a mean± SD age of 37.2 ± 10.5 years. Hepatic cysts were present in 79.3% of patients, urinary tract infections, nephrolithiasis, macroscopic hematuria and pain in 44.3%, 42.5%, 24.8% and 54.4% respectively. A history of intracranial bleeding in family was positive in 21.5%. In multivariable analysis, lower eGFR was associated with younger age at the time of APKD diagnosis (p < 0.002), younger age at hypertension diagnosis (p < 0.08) and greater values of TKV (p < 0.001), height adjusted TKV (p < 0.001) and Body Mass Index (BMI) (p = 0.02)

Conclusion

In this study, patients with ADPKD were diagnosed at a young age and hypertension developed early on the course of the disease. Both these factors together with higher values of BMI and TKV were independently associated with low eGFR